News

The share of Indian medicines in the Ukrainian pharmaceutical market since the beginning of 2024 was about 4%

The share of Indian medicines has been about 4% of the Ukrainian pharmaceutical market since the beginning of 2024, said the president of the Indian Pharmaceutical Manufacturer’s Association (IPMA), Dr. Menon R.U.P. “India's share in the first quarter of 2024 was about 4%, and India ranks seventh,” he told the Interfax-Ukraine agency. Menon stressed that, despite the stabilization of the pharmaceutical market since

The share of Indian medicines in the Ukrainian pharmaceutical market since the beginning of 2024 was about 4%

The share of Indian medicines has been about 4% of the Ukrainian pharmaceutical market since the beginning of 2024, said the president of the Indian Pharmaceutical Manufacturer’s Association (IPMA), Dr. Menon R.U.P.

“India's share in the first quarter of 2024 was about 4%, and India ranks seventh,” he told the Interfax-Ukraine agency.

Menon stressed that, despite the stabilization of the pharmaceutical market since the beginning of 2024, “sales of hospital drugs have decreased, because hospitals still have a lot of humanitarian aid.”

At the same time, commenting on the logistics of pharmaceutical products from India to Ukraine in wartime, Menon noted that the delivery route from India to Ukraine is currently complicated, because direct air and sea shipments are not possible during martial law.

“Delivery is carried out through European ports and from there by road to Ukraine. Logistics from India takes a lot of time and is expensive,” he stated.

At the same time, Menon added that large international Indian pharmaceutical companies continue to operate in Ukraine through their local warehouses and supply medicines to leading Ukrainian distributors. Indian pharmaceutical manufacturers also continue to take part in public procurement, in particular of drugs for treating HIV/AIDS, tuberculosis and oncological diseases.

According to him, demand remains in the retail segment for Indian drugs for older age groups, stress-management drugs and sedatives.

Menon stressed that all IPMA member companies have been contributing to Ukraine's victory and helping Ukrainians since the first days of the full-scale war.

In particular, Indian pharmaceutical companies have provided pharmaceutical goods worth about $16.6 million as humanitarian aid during the full-scale war.

In the first days after the missile attack on the national specialized children's hospital Okhmatdyt in Kyiv, IPMA also joined the relief effort and made a charitable contribution of half a million hryvnias to the hospital's account.

“All members of our Association have, since the beginning of the war, mobilized without hesitation to help Ukraine, donating and continuing to donate necessary medicines, material and financial resources both to Ukraine and to non-governmental organizations, and supporting Ukrainian citizens who were forced to leave their homes,” Menon said.

In addition, IPMA joined the initiative of the president of Ukraine, Volodymyr Zelensky, UNITED24, and transferred half a million hryvnias to the special account of the National Bank of Ukraine in support of the Ukrainian armed forces.

IPMA unites companies that meet the international standards of the FDA (USA), Health Canada (Canada), the MHRA (UK), the EMA (EU), the MCC (South Africa), the TGA (Australia), WHO GMP (WHO) and GMP (Ukraine) and have representative offices in Ukraine. The Indian Pharmaceutical Manufacturers Association (IPMA) represents the interests of leading Indian pharmaceutical manufacturers on the Ukrainian market, which helps provide the population of Ukraine with high-quality, safe, effective and affordable medicines.

Today the permanent members of IPMA are the international companies Abryl Pharm LLC, Dia Pharma Limited, Dr.Reddy’s, Euro Lifecare Ltd, Hetero Labs Limited, M.Biotech Limited, Macleods Pharmaceutical Limited LLC, Mega Lifesciences LLC, Sun Pharma and Zandra Life Sciences PVT. LTD.
Indian prime minister Narendra Modi intends, during his visit to Kyiv, to discuss with the president, Volodymyr Zelensky, the possibilities of a peaceful end to the Russian-Ukrainian war.

“I look forward to the opportunity to continue my earlier conversations with Zelensky on strengthening bilateral cooperation and to share views on a peaceful settlement of the ongoing conflict in Ukraine,” reads a statement by Modi published on Wednesday by his office.

The Indian prime minister will visit Ukraine on August 23 and meet with the president, Zelensky.
Earlier, India's foreign ministry stressed that this is a “historic visit, as the Indian prime minister will visit Ukraine for the first time in more than 30 years of diplomatic relations.”